Corcept Therapeutics Incorporated (CORT) Debt/EBITDA US GAAP (year values)

2020 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA -3.70 -3.64 -2.69 -3.87 -3.40   -2.58  
Changes by years, y/y, % +35% -2% -26% +44% -12%     +8.0%

Corcept Therapeutics Incorporated. Debt/EBITDA

Corcept Therapeutics Incorporated. Debt/EBITDA, changes, %

Corcept Therapeutics Incorporated (CORT) Debt/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA -3.59 -3.39 -3.33 -3.63 -2.58   -2.58
Changes by years, y/y, % +18% -11% -27% +1% -28%    
Changes by quarters, q/q, % -1% -6% -2% +9% -29%    

Corcept Therapeutics Incorporated. Debt/EBITDA

Corcept Therapeutics Incorporated. Debt/EBITDA, changes, y/y, %

Corcept Therapeutics Incorporated. Debt/EBITDA, changes, q/q, %